Orphan Medical submits NDA

ORPH submitted an NDA to the FDA for Xyrem sodium oxybate, an oral solution based on gamma hydroxybutyrate (GHB), to treat cataplexy and excessive daytime sleepiness (EDS) associated with narcolepsy. ...